
ICON Public Limited Company ICLR
$ 118.48
1.19%
Annual report 2024
added 04-18-2026
ICON Public Limited Company P/E Ratio 2011-2026 | ICLR
Annual P/E Ratio ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 42 | 35.7 | 116 | 32.4 | 24.3 | 23.5 | 21.1 | 17.5 | 16.6 | 20.6 | 25.7 | 31.6 | 50.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 116 | 16.6 | 34.2 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 1.32 | -19.18 % | $ 1.76 M | ||
|
Agilent Technologies
A
|
34.7 | $ 112.44 | -0.71 % | $ 34.2 B | ||
|
Castle Biosciences
CSTL
|
-19.5 | $ 19.2 | 1.69 % | $ 557 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 15.88 | -1.91 % | $ 480 M | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
-13.4 | $ 140.85 | -1.67 % | $ 22.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 19.88 | -2.98 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 94.55 | -2.2 % | $ 6.38 B | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 419.78 | 0.15 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
32.7 | $ 1 051.07 | 0.88 % | $ 21.7 B | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 3.65 | 0.69 % | $ 338 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
-13.7 | $ 8.32 | -0.54 % | $ 1.07 B | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
27.2 | $ 18.64 | -1.53 % | $ 417 M | ||
|
Natera
NTRA
|
-9.69 | $ 188.14 | -4.45 % | $ 18.5 B | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 155.97 | -1.98 % | $ 7.73 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
33.8 | $ 25.36 | -0.55 % | $ 24 B | ||
|
Guardant Health
GH
|
-32.3 | $ 93.95 | -4.77 % | $ 11.8 B | ||
|
Personalis
PSNL
|
-5.3 | $ 6.56 | -2.24 % | $ 585 M | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 5.71 | -1.89 % | $ 238 M | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
99.7 | $ 52.98 | -0.02 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.36 | -2.07 % | $ 5.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 252.76 | -0.5 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
29.3 | - | - | $ 167 B | ||
|
Trinity Biotech plc
TRIB
|
-6.21 | $ 0.56 | -3.75 % | $ 201 M | ||
|
Celcuity
CELC
|
-30.3 | $ 134.53 | -0.14 % | $ 6.29 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
-20.1 | $ 48.6 | -8.22 % | $ 2.91 B | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 8.32 | -1.25 % | $ 1.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 187.2 | -0.39 % | $ 20.8 B | ||
|
Invitae Corporation
NVTA
|
-5.12 | - | - | $ 21.2 M |